Pancreatic Cancer Research

ResearcherMemorial Sloan Kettering Cancer CenterActive in the last 2 years

Luisa F. Escobar‐Hoyos

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0001-6425-0461; OpenAlex author ID A5079259494. Sources: OpenAlex.

Their work

Papers
15 (first author 0, last author 6)
Trials
0
Grants
1
Labs led
1
Collaborators
53
Papers, trials and grants by year

2017: 1 grant · 2018: none · 2019: 1 paper · 2020: 2 papers · 2021: 2 papers · 2022: 2 papers · 2023: none · 2024: 3 papers · 2025: 1 paper · 2026: 4 papers

Papers 15

  1. Network divergence analysis identifies adaptive gene modules and two orthogonal vulnerability axes in pancreatic cancer. Co-author DOI 10.1002/1878-0261.70218↗
  2. Mitochondrial-Localized Keratin 17 Promotes Chemoresistance in Basal-like Pancreatic Cancer. Last author DOI 10.1158/0008-5472.can-25-4534↗
  3. A KRT17/GATA6 hybrid state marks unique vulnerability to MYC in pancreatic cancer Co-author DOI 10.21203/rs.3.rs-11519779/v1↗
  4. Continuous tissue fields organize immune composition in pancreatic cancer Co-author DOI 10.64898/2026.08.22.746444↗
  5. Advancing Precision Medicine in PDAC: An Ethical Scoping Review and Call to Action for IHC Implementation. Co-author DOI 10.3390/cancers17121899↗
  6. Perioperative Modified FOLFIRINOX for Resectable Pancreatic Cancer: A Nonrandomized Controlled Trial. Co-author DOI 10.1001/jamaoncol.2024.1575↗
  7. Keratin 17 is a prognostic and predictive biomarker in pancreatic ductal adenocarcinoma. Last author DOI 10.1093/ajcp/aqae038↗
  8. Keratin 17 modulates the immune topography of pancreatic cancer. Co-author DOI 10.1186/s12967-024-05252-1↗
  9. Targeting keratin 17-mediated reprogramming of de novo pyrimidine biosynthesis to overcome chemoresistance in pancreatic cancer Last author DOI 10.1101/2022.08.24.504873↗
  10. Disassembly of embryonic keratin filaments promotes pancreatic cancer metastases Last author DOI 10.1101/2022.08.27.504988↗
  11. Keratin 17 testing in pancreatic cancer needle aspiration biopsies predicts survival. Co-author DOI 10.1002/cncy.22438↗
  12. Pancreatic cancer driver mutations are targetable through distant alternative RNA splicing dependencies. Last author DOI 10.18632/oncotarget.27901↗
  13. An unbiased high-throughput drug screen reveals a potential therapeutic vulnerability in the most lethal molecular subtype of pancreatic cancer. Co-author DOI 10.1002/1878-0261.12743↗
  14. Altered RNA Splicing by Mutant p53 Activates Oncogenic RAS Signaling in Pancreatic Cancer. Co-author DOI 10.1016/j.ccell.2020.05.010↗
  15. Keratin 17 identifies the most lethal molecular subtype of pancreatic cancer. Last author DOI 10.1038/s41598-019-47519-4↗

Grants 1

  1. mRNA Splicing in Pancreatic Adenocarcinoma AWARD pancan:2017-luisa-escobar-hoyos-mrna-splicing-in-pancreatic-adenocarcino

Closest collaborators

The 25 strongest of 53 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kenneth Reed Shroyer · 14 shared papers, 2019–2026 · strength 2.44
  2. Lyanne Delgado Coka · 7 shared papers, 2024–2026 · strength 1.64
  3. Lucia Roa‐Peña · 8 shared papers, 2019–2026 · strength 1.37
  4. Scott Powers · 3 shared papers, 2026 · strength 0.77
  5. Chun‐Hao Pan · 6 shared papers, 2019–2026 · strength 0.74
  6. Shayan Sarkar · 2 shared papers, 2026 · strength 0.48
  7. Ryan R. Kawalerski · 3 shared papers, 2020–2022 · strength 0.46
  8. Nina V. Chaika · 2 shared papers, 2022–2026 · strength 0.34
  9. Pankaj Kumar Singh · 2 shared papers, 2022–2026 · strength 0.34
  10. Emanuel F. Petricoin · 2 shared papers, 2024 · strength 0.33
  11. Andrew Eugene Hendifar · 2 shared papers, 2024 · strength 0.33
  12. Brent K. Larson · 2 shared papers, 2024 · strength 0.33
  13. Wei Jiang · 2 shared papers, 2024 · strength 0.33
  14. Lynn McCormick Matrisian · 2 shared papers, 2024 · strength 0.33
  15. Steven D Leach · 2 shared papers, 2020–2021 · strength 0.29
  16. Brian Nelson · 1 shared paper, 2026 · strength 0.29
  17. Mikala Egeblad · 1 shared paper, 2026 · strength 0.27
  18. Weihao Wang · 1 shared paper, 2026 · strength 0.27
  19. Marie C. Hasselluhn · 1 shared paper, 2026 · strength 0.27
  20. Mara H. Sherman · 1 shared paper, 2026 · strength 0.27
  21. Despina Siolas · 1 shared paper, 2026 · strength 0.27
  22. Emanuel F. Petricoin · 1 shared paper, 2026 · strength 0.21
  23. David Arthur Tuveson · 1 shared paper, 2026 · strength 0.21
  24. Minsig Choi · 1 shared paper, 2024 · strength 0.17
  25. Vincent J. Picozzi · 1 shared paper, 2024 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.